Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.
Geoffrey Y. Ku, MD
Advertisement
Articles by Geoffrey Y. Ku, MD
Ahead of the 2017 ASCO Gastrointestinal Cancer Symposium in San Francisco, we spoke with Dr. Geoffrey Ku on the advances in systemic therapy for esophageal and gastric cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
AI and MRD Take Center Stage on Day 2 of ASCO Breakthrough 2026
2
Pirtobrutinib Earns Positive CHMP Opinion Across All CLL Treatment Lines
3
40 An AI Digital Twin Compares Favorably to Radiologists for Landmark Identification and Measurement in Early-Stage Breast Cancer: A Retrospective, Multi-Institution Clinical Study
4
GLP-1 Receptor Agonists Reduce Colorectal Cancer Risk in IBD Populations
5